Share on LinkedInShare on LinkedIn

ARTICLE · 19 FEBRUARY 2026

Pay-for-Delay Agreements In Türkiye: Between Patent Protection And Competition Law

Moroglu Arseven
Moroglu Arseven
Contributor
Moroglu Arseven

Moroglu Arseven

Celebrating its 25th year, Moroğlu Arseven is an independent, full-service Turkish law firm...

View firm profile
Explore more from Moroglu Arseven

The pharmaceutical industry is a strategically significant sector in which advanced, high-cost products are developed, substantial investments are made in research and development, patents, and licensing, and which plays a critical role both in protecting public health and in shaping the public economy.

TurkeyIntellectual Property

The pharmaceutical industry is a strategically significant sector in which advanced, high-cost products are developed, substantial investments are made in research and development, patents, and licensing, and which plays a critical role both in protecting public health and in shaping the public economy.

In Türkiye, pharmaceutical products for human use cannot be marketed unless they are authorized by the Ministry of Health ("MoH"). To grant pharmaceutical license and marketing authorization, MoH requires pharmaceutical companies to submit the results of their pharmaceuticals' safety and efficacy tests, along with other documents regarding the product.

In effect, pharmaceutical companies must invent and develop a pharmaceutical product through intensive and time-consuming research and development activities, then provide the results of the toxicological and pharmacological tests and clinical trials to MoH in order to commercially exploit their product. This is a

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from